Active Pharmaceutical Ingrediants - Product Information

Home > Business Segment > Active Pharmaceutical Ingrediants > Product Information

API-Product List

S. No. Product Name Innovator Brand Name Therapeutic Segment DMF/COS/ Technical(Package Status)
1 Loratadine Process-1 (USP/EP) Claritin Anti-histaminic USDMF, EDMF, CDMF
2 Loratadine Process-2 (USP/EP) Claritin Anti-histaminic USDMF, COS, JDMF, TDMF, CNDMF
3 Desloratadine (ICH/EP/USP) Clarinex Anti-histaminic USDMF, EDMF, COS , TDMF, IDL China
4 Atorvastatin Calcium Crystalline Trihydrate (USP/EP/ICH/JP/IP) Lipitor Anti-hypercholesterolemic USDMF, EDMF, COS, TDMF,CDMF
5 Atorvastatin Calcium Amorphous (USP/ICH) Lipitor Anti-hypercholesterolemic DMF
6 Atorvastatin Calcium Crystalline Form VI (USP/EP/ICH) Lipitor Anti-hypercholesterolemic TDMF
7 Montelukast Sodium Amorphous (USP/EP/ICH/JP/IP) Singulair Anti-asthmatic USDMF, COS, CDMF & IDL China
8 Montelukast Sodium Crystalline (USP/EP/ICH/JP) Singulair Anti-asthmatic Tech Package
9 Fexofenadine Hydrochloride (USP/EP/JP/IP) Allegra Anti-histaminic USDMF, EDMF, COS, JDMF Filed, CNDMF
10 Rosuvastatin Calcium Crystalline (USP/EP/ICH/IP) Crestor Anti-hypercholesterolemic USDMF, COS & TDMF
11 Rosuvastatin Calcium amorphous (USP/EP/ICH/IP) Crestor Anti-hypercholesterolemic EDMF, COS, USDMF
12 Sitagliptin Phosphate (USP/EP/ICH) Januvia Anti-diabetic USDMF, TDMF, COS Filed, EDMF
13 Olmesartan Medoxomil (USP/EP/ICH/JP/IP) Benicar Anti-hypertensive DMF
14 Candesartan Cilexetil (USP/EP/ICH/JP/IP) Atacand Anti-Hypertensive DMF
15 Saxagliptin Hydrochloride (ICH/IH) Onglyza Anti-diabetic USDMF
16 Linagliptin (ICH/IH) Tradjenta Anti-diabetic DMF
17 Voglibose (JP/IP) Basen Anti-diabetic Tech Package
18 Dapagliflozin Propanediol (ICH/IH) Farxiga Anti-diabetic Tech Package
19 Dapagliflozin Amorphous (ICH/IH) Farxiga Anti-diabetic Tech Package
20 Empagliflozin (ICH/IH) Jardiance Anti-diabetic DMF
21 Canagliflozin Hemihydrate (ICH/IH) Invokana Anti-diabetic Tech Package
22 Vildagliptin (ICH/IH) Galvus Anti-diabetic Tech Package
23 Alogliptin Benzoate (ICH/IH) Nesina Anti-diabetic Tech Package

Note: The above products are for R&D purpose only & not for commercial sale where the patents are applicable & still valid

API-Under Development List

S. No. Product Name Innovator Brand Name Therapeutic Segment
1 Apixaban Bristol Meyer Squibb Eliquis Anti-coagulant
2 Biperidene Hydrochloride Knoll Gmbh. Akineton Desiperiden Anti-Parkinsonian
3 Edoxaban Tosylate Daiichi Sankyo Savaysa Anti-coagulant
4 Elagolix Sodium Abbvie Orilissa GnRH Antagonist
5 Ertugliflozin Pfizer/ Merck Steglatro Anti-diabetic
6 Febuxostat Teijin Uloric Anti-Gout
7 Ivacaftor Vertex Pharma Kalydeco Transmembrane conductance regulator
8 Rivaroxaban Bayer/ Janssen Pharma Xarelto Anti-coagulant
9 Rupatadine Fumarate J Uriach & Cia Rupafin Antihistaminic
10 *Ursodeoxycholic Acid (UDCA)  - Urso DS/Forte Actigall Delursan Treat Primary Biliary Cirrhosis
11 Vortioxetine Hydrobromide Takeda Pharma. Trintellix Anti-Depressant

Note: The above products are not for sale where the patents are applicable & still valid

*The drug Ursodeoxycholic acid (UDCA) is of animal origin and was first Identified in 1902 from polar bear bile by Hammarsten whereas UDCA was isolated and crystallised first time by Shoda in 1927. In 1936, its chemical structure was determined by Iwasaki at Okoyama Medical University. Several years later (1954) a chemist at Tokyo Institute of Technology, Kanazawa, described a Method of synthesising UDCA from cholic acid and Chenodeoxycholic acid. Three years later (1957), Tokyo Tanabe Pharmaceutical Company launched ‘‘Urso’’ in Japan as a choleretic that could improve symptoms related to liver dysfunction and maldigestion. It was approved by USFDA in December 1987 to Allergen and it is marketed as Actigall by Allergen in US.